{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:40:52Z","timestamp":1787312452888,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82305332"],"award-info":[{"award-number":["82305332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273963"],"award-info":[{"award-number":["82273963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin","doi-asserted-by":"crossref","award":["25JCLMJC00190"],"award-info":[{"award-number":["25JCLMJC00190"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin","doi-asserted-by":"crossref","award":["24JCZDJC00770"],"award-info":[{"award-number":["24JCZDJC00770"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-026-00342-4","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:05:13Z","timestamp":1778565913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["4-Hydroxychalcone Exert the Anti-cancer Potential in Colorectal Cancer Through Targeting CDK6"],"prefix":"10.1186","volume":"28","author":[{"given":"Chenxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Huangfu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"1","key":"342_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"342_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, et al. Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 2023;41(3):678\u2013700.","journal-title":"J Clin Oncol"},{"issue":"9","key":"342_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-020-02959-z","volume":"11","author":"L Walter","year":"2020","unstructured":"Walter L, Canup B, Pujada A, Bui TA, Arbasi B, Laroui H, et al. Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer. Cell Death Dis. 2020;11(9):767.","journal-title":"Cell Death Dis"},{"key":"342_CR4","doi-asserted-by":"crossref","unstructured":"Qureshi MJ, Narde GK, Ahuja A, Meenakshi DU, Al Balushi K. Combination therapy using phytochemicals and PARP inhibitors in hybrid nanocarriers: an optimistic approach for the management of colon cancer. Int J Mol Sci. 2025;26(15):7350.","DOI":"10.3390\/ijms26157350"},{"issue":"2","key":"342_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"issue":"4","key":"342_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular senescence: defining a path forward. Cell. 2019;179(4):813\u201327.","journal-title":"Cell"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 2022;85:4\u201332.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"342_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41419-022-05486-1","volume":"13","author":"M Maheshwari","year":"2022","unstructured":"Maheshwari M, Yadav N, Hasanain M, Pandey P, Sahai R, Choyal K, et al. Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate. Cell Death Dis. 2022;13(12):1045.","journal-title":"Cell Death Dis"},{"issue":"10","key":"342_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41580-024-00765-5","volume":"25","author":"P Nurse","year":"2024","unstructured":"Nurse P. The discovery of cyclin-dependent kinases. Nat Rev Mol Cell Biol. 2024;25(10):763.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"342_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","volume":"22","author":"S Goel","year":"2022","unstructured":"Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer. 2022;22(6):356\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"342_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/1078-0432.CCR-18-2177","volume":"25","author":"M Malumbres","year":"2019","unstructured":"Malumbres M. CDK4\/6 inhibitors: what is the best cocktail? Clin Cancer Res. 2019;25(1):6\u20138.","journal-title":"Clin Cancer Res"},{"issue":"20","key":"342_CR12","doi-asserted-by":"publisher","first-page":"e202200706","DOI":"10.1002\/asia.202200706","volume":"17","author":"S Mastachi-Loza","year":"2022","unstructured":"Mastachi-Loza S, Ram\u00edrez-Candelero TI, Ben\u00edtez-Puebla LJ, Fuentes-Ben\u00edtes A, Gonz\u00e1lez-Romero C, V\u00e1zquez MA. Chalcones, a privileged scaffold: highly versatile molecules in [4+2] cycloadditions. Chem Asian J. 2022;17(20):e202200706.","journal-title":"Chem Asian J"},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"110297","DOI":"10.1016\/j.cbi.2022.110297","volume":"369","author":"AA WalyEldeen","year":"2023","unstructured":"WalyEldeen AA, Sabet S, El-Shorbagy HM, Abdelhamid IA, Ibrahim SA. Chalcones: promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer. Chem Biol Interact. 2023;369:110297.","journal-title":"Chem Biol Interact"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"1670759","DOI":"10.1155\/2019\/1670759","volume":"2019","author":"AM Alshangiti","year":"2019","unstructured":"Alshangiti AM, Tuboly E, Hegarty SV, McCarthy CM, Sullivan AM, O\u2019Keeffe GW. 4-Hydroxychalcone induces cell death via oxidative stress in MYCN-amplified human neuroblastoma cells. Oxid Med Cell Longev. 2019;2019:1670759.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"342_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/toxres\/tfaa091","volume":"10","author":"A Nazari","year":"2021","unstructured":"Nazari A, Mirian M, Aghaei M, Aliomrani M. 4-Hydroxyhalcone effects on cisplatin-induced genotoxicity model. Toxicol Res. 2021;10(1):11\u20137.","journal-title":"Toxicol Res"},{"issue":"10","key":"342_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18(10):611\u201327.","journal-title":"Nat Rev Nephrol"},{"issue":"03","key":"342_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/HM9.0000000000000124","volume":"4","author":"K Zhao","year":"2024","unstructured":"Zhao K, Su X, Pang W, Wang Y, Li H, Zhang Y, et al. Retrospective cohort study on the postoperative survival rate enhancement of patients with colorectal cancer using three traditional Chinese medicine formulations: evidence from 1,361 cases. Acupunct Herbal Med. 2024;4(03):399\u2013404.","journal-title":"Acupunct Herbal Med"},{"issue":"1","key":"342_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43018-024-00893-z","volume":"6","author":"JJ Asciolla","year":"2025","unstructured":"Asciolla JJ, Wu X, Adamopoulos C, Gavathiotis E, Poulikakos PI. Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer. Nat Cancer. 2025;6(1):24\u201340.","journal-title":"Nat Cancer"},{"issue":"11","key":"342_CR19","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-21-2428","volume":"82","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Golomb L, Meyerson M. Functional genomic analysis of CDK4 and CDK6 gene dependency across human cancer cell lines. Cancer Res. 2022;82(11):2171\u201384.","journal-title":"Cancer Res"},{"issue":"6","key":"342_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s13402-022-00714-4","volume":"45","author":"W Chen","year":"2022","unstructured":"Chen W, Zhang W, Chen M, Yang C, Fang T, Wang H, et al. Applications and mechanisms of the cyclin-dependent kinase 4\/6 inhibitor, PD-0332991, in solid tumors. Cell Oncol (Dordr). 2022;45(6):1053\u201371.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"342_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","volume":"37","author":"M Alvarez-Fernandez","year":"2020","unstructured":"Alvarez-Fernandez M, Malumbres M. Mechanisms of sensitivity and resistance to CDK4\/6 inhibition. Cancer Cell. 2020;37(4):514\u201329.","journal-title":"Cancer Cell"},{"issue":"2","key":"342_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-17-0915","volume":"8","author":"J Deng","year":"2018","unstructured":"Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, et al. CDK4\/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov. 2018;8(2):216\u201333.","journal-title":"Cancer Discov"},{"issue":"22","key":"342_CR23","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1016\/j.molcel.2023.10.016","volume":"83","author":"L Crozier","year":"2023","unstructured":"Crozier L, Foy R, Adib R, Kar A, Holt JA, Pareri AU, et al. CDK4\/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence. Mol Cell. 2023;83(22):4062-4077.e5.","journal-title":"Mol Cell"},{"issue":"5","key":"342_CR24","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29(5):946\u201360.","journal-title":"Cell Death Differ"},{"issue":"1","key":"342_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-022-01360-x","volume":"15","author":"S Li","year":"2022","unstructured":"Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol. 2022;15(1):147.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"342_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41418-022-01069-x","volume":"30","author":"AP Tran","year":"2023","unstructured":"Tran AP, Tralie CJ, Reyes J, Moosm\u00fcller C, Belkhatir Z, Kevrekidis IG, et al. Long-term p21 and p53 dynamics regulate the frequency of mitosis events and cell cycle arrest following radiation damage. Cell Death Differ. 2023;30(3):660\u201372.","journal-title":"Cell Death Differ"},{"issue":"3","key":"342_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","volume":"5","author":"S Chaib","year":"2024","unstructured":"Chaib S, L\u00f3pez-Dom\u00ednguez JA, Lalinde-Guti\u00e9rrez M, Prats N, Marin I, Boix O, et al. The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat Cancer. 2024;5(3):448\u201362.","journal-title":"Nat Cancer"},{"issue":"3","key":"342_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cac2.12636","volume":"45","author":"C Shao","year":"2025","unstructured":"Shao C, Zhang Y, Li H, Chen J, Huang T, Li J, et al. Radiotherapy-resistant prostate cancer cells escape immune checkpoint blockade through the senescence-related ataxia telangiectasia and Rad3-related protein. Cancer Commun (Lond). 2025;45(3):218\u201344.","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"342_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tig.2022.02.010","volume":"38","author":"PL Vaddavalli","year":"2022","unstructured":"Vaddavalli PL, Schumacher B. The p53 network: cellular and systemic DNA damage responses in cancer and aging. Trends Genet. 2022;38(6):598\u2013612.","journal-title":"Trends Genet"},{"key":"342_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jare.2024.07.029","volume":"72","author":"C Zhang","year":"2025","unstructured":"Zhang C, Liu X, Gu C, Su Y, Lv J, Liu Y, et al. Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6\/ID2 axis. J Adv Res. 2025;72:633\u201352.","journal-title":"J Adv Res"},{"issue":"1","key":"342_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-025-04179-8","volume":"16","author":"W Chen","year":"2025","unstructured":"Chen W, Zhou L, Jiang J, Chen J, Geng D, Chen Y, et al. Induction of the p21\/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma. Stem Cell Res Ther. 2025;16(1):63.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"342_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-025-02355-1","volume":"24","author":"Y Zou","year":"2025","unstructured":"Zou Y, Zhang H, Chen P, Tang J, Yang S, Nicot C, et al. Clinical approaches to overcome PARP inhibitor resistance. Mol Cancer. 2025;24(1):156.","journal-title":"Mol Cancer"},{"issue":"12","key":"342_CR33","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.1021\/acs.jmedchem.5c01058","volume":"68","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yin F, Luo Z, Zheng Y, Guo S, Wu S, et al. Design and synthesis of PARP\/CDK6 dual-target inhibitors modulating of Wnt\/\u03b2-Catenin signaling pathway for the treatment of BRCA wild-type TNBC. J Med Chem. 2025;68(12):13030\u201356.","journal-title":"J Med Chem"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-026-00342-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:03:39Z","timestamp":1783605819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12575-026-00342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1186\/s12575-026-00342-4","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Laboratory Animal Ethics Committee Nankai University (protocol code: 2021-SYDWLL-000069). Tumor tissues were obtained from CRC patients during surgery, which provided by Tianjin Union Medical Center (Tianjin, China). The study was conducted in accordance with the Declaration of Helsinki and approved by the Requirements of the Ethical Review System of Biomedical Research Involving Human by National Health and Family Planning Commission of China, Nankai University and Tianjin Union Medical Center Ethics Committee (protocol code: NKUIRB2021022). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"29"}}